Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation

Rheumatology (Oxford). 2017 Dec 1;56(12):2256. doi: 10.1093/rheumatology/kex348.

Giulio Cavalli^{1

2

3}, Marije Koenders⁴, Vassili Kalabokis⁵, Jihye Kim⁶, Aik Choon Tan⁶, Cecilia Garlanda⁷, Alberto Mantovani⁷, Lorenzo Dagna², Leo A B Joosten³, Charles A Dinarello^{1

3}

¹ Department of Medicine, University of Colorado Denver, Aurora, CO, USA.
² Internal Medicine and Clinical Immunology, Vita-Salute San Raffaele University, Milan, Italy.
³ Department of Internal Medicine.
⁴ Department of Rheumatology, Radboud University Medical Centre, Nijmegen, The Netherlands.
⁵ R&D Systems, BioTechne, Inc., Minneapolis, MN.
⁶ Translational Bioinformatics, Division of Medical Oncology, University of Colorado Denver, Aurora, CO, USA.
⁷ Research Institute Humanitas, Experimental Immunopathology Lab, Rozzano, Italy.

No abstract available

Publication types